In addition to the standard checks conducted by the manufacturer before a batch of vaccines is released for sale, all vaccine batches undergo, prior to their release onto the market in the European Union, an inspection by the French National Agency for Medicines and Health Products Safety (ANSM) or by another European health authority, in accordance with the principle of mutual recognition of inspections.
This dual inspection provides an additional guarantee of the safety and quality of vaccines.